Reuters logo
BRIEF-Mirati Therapeutics says estimates had between $56 mln and $57 mln in cash and short-term investments as of Dec 31 - SEC filing
January 5, 2017 / 9:16 PM / 8 months ago

BRIEF-Mirati Therapeutics says estimates had between $56 mln and $57 mln in cash and short-term investments as of Dec 31 - SEC filing

Jan 5 (Reuters) - Mirati Therapeutics Inc

* Mirati Therapeutics - estimate had between $56 million and $57 million in cash, cash equivalents and short-term investments as of Dec 31, 2016 - SEC filing Source text: (bit.ly/2jg040M) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below